Pricing Log in Create free account

Alpha Tau Medical Ltd. (DRTS) vs Nektar Therapeutics (NKTR)

Alpha Tau Medical Ltd. and Nektar Therapeutics are both Biotechnology companies. Alpha Tau Medical Ltd. and Nektar Therapeutics are of similar size ($1.3B and $1.2B). Alpha Tau Medical Ltd. has the higher net margin (0.00% vs −287.8%) and the higher return on invested capital (0.00% vs −40.2%). Across the 14 metrics below, Alpha Tau Medical Ltd. leads on 10 and Nektar Therapeutics on 4.

Valuation

Metric DRTS NKTR Biotechnology median
P/E n/m n/m 8.50
P/S n/m 21.67 9.71
P/B 25.03 1.31 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 18.33 9.21
Earnings yield (4.56%) (18.73%) (33.15%)
Free cash flow yield (3.55%) (19.79%) (25.50%)

Profitability

Metric DRTS NKTR Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (257.80%) 0.00%
Net margin 0.00% (287.84%) 0.00%
Free cash flow margin 0.00% (428.72%) 0.00%
Return on equity 0.00% (35.75%) (56.36%)
Return on assets 0.00% (24.12%) (48.04%)
Return on invested capital 0.00% (40.20%) 0.00%

Growth

Metric DRTS NKTR Biotechnology median
Revenue growth (TTM) — (27.15%) 6.02%
EPS growth (last fiscal year) (17.78%) (11.89%) 30.26%
Revenue growth, 5-year CAGR — (18.43%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DRTS NKTR Biotechnology median
Debt to equity 0.15 0.00 0.00
Current ratio 11.09 10.42 4.72
Net debt to EBITDA 1.63 1.77 0.96

Dividend

Metric DRTS NKTR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DRTS NKTR Biotechnology median
Market cap 1.22b 1.29b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack